Pharma stocks face volatility on us plan to reduce drug prices

WHO IS WINNING BETWEEN NOVO-NORDISK AND ELI LILLY?

Bond investors are more cautious, while JPMorgan boss warns of a ‘crack’ coming

It could take a long time to reverse decades of lagging behind the US

Long-term bond yields have risen despite weakening economic data

A whistle-stop tour of new faces, farewells, winners and losers

Germany isn’t the only magnet as investors are also warming to global ex-US funds